Live in-person:

6 - 9 February 2023

Dubai World Trade Centre

 16 Jan - 9 Mar 2023



The evidence and impact of rapid testing to strengthen the healthcare system and patient care



 Tuesday 7th February I 14:00 - 18:00

 Johannesburg room I Z1.D10




Session summary

Healthcare professionals are encouraged to join this clinical and scientific session for updates on the use of Point of Care diagnostics for COVID-19 and Influenza testing in decentralized settings. Investigators and clinical experts will share their research and practical experience with point of care testing. The availability of timely results and its impact on patient management and antimicrobial resistance prevention.

Learning objectives

  • Discuss the importance of an early differential diagnosis of COVID-19 and Influenza
  • Share study and practical experience with POC testing
  • Explore the evidence describing the impact of an early and accurate diagnosis on infection control and antibiotic resistance  prevention

Session summary

Gaps in diagnostics and monitoring treatment of HIV are perpetuating the epidemic. While progress has been made, barriers to HIV testing remain with failure to identify new cases, missing diagnostic in the acute phase and Lost of follow up, which are impacting the achievement of UNAID's 95/95/95 goals. Increasing  knowledge of HIV status is a must. Early detection of individuals in the highly infectious acute phase is a key factor in reducing transmission. A reduction in lost to follow up patients by providing results immediately is a key element in the fight against AIDS. Join this program for insights on rapid, accessible, and accurate testing methods. 

Learning objectives

  • Review the status of HIV infections, current factors for HIV transmission and diagnostic gaps
  • Examine the importance of early detection and treatment
  • Describe strategies to enhance screening and improve patient and community outcomes
  • Discuss test types and the rationale for rapid 4th generation HIV testing

Session summary

Healthcare professionals are encouraged to join this Market Access session looking into policy adoption for Point of Care. Our key speakers will share recent successful Point of Care policy change adopted in UAE for respiratory diseases, and the strategy that can be used to implement Point of Care test and treat. The session will focus on the increasing burden of AMR in the Middle East region and how Point of Care can reduce this burden.

Learning objectives

  • Understanding the Burden of AMR in the Middle East region
  • Creating policies for testing for Infectious diseases
  • Creating clear KPI’s for case management to support better patient outcomes 

Company bio

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 113,000 colleagues serve people in more than 160 countries.